Wednesday, 24 April 2019

Drug Discovery News

  • FDA gets biomarker database license from GVK Bio

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US FDA. The Gobiom database, which has the latest and re...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • NIH study: Diabetes drug Metformin extends life

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

  • Accelerating drug discovery process

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platforms to develop new drugs. Many biotechnology researchers and entreprene...Read more

  • Boehringer to open $46 mn biologics plant in Shanghai

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing to Chinese companies developing their own drugs....Read more

  • Recycled plastic can kill drug-resistant fungi

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research Almaden have discovered a new, potentially life-saving application f...Read more

  • Novartis liver cancer trial with Afinitor flops

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

  • Oramed submits pre-IND for exenatide to FDA

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

  • Aussie drug delivery firm raises $19.3 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and A...Read more

  • Bayer initiates Phase II/III trial of a new compound for Hemophilia A

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more

  • APAC ovarian cancer drug market to grow modestly'

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • Deal with Janssen gets Astellas $65 million up-front

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to develop and commercialize ASP015K, an Astellas compound, worldwide e...Read more

  • Lorcaserin receives positive vote from FDA advisory committee

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to four, with one abstention, at a meeting held on ...Read more

  • Biodiem gets US patent allowance for antifungal therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

  • Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102

    Drug Discovery |  News | 0 Comment | 22 Feb, 2017

    Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan diseases, today announces that its lead compound MIN-102 has been grant...Read more

  • Apollo Therapeutics launched the first drug discovery programme

    Drug Discovery |  News | 0 Comment | 22 Feb, 2017

    Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutical companies, has invested in and launched the first of its drug disc...Read more

  • New CoolPal Vertos Advance launched by Pelican BioThermal

    Drug Discovery |  News | 0 Comment | 19 Jan, 2017

    US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-controlled packaging solutions serving the life sciences industry has r...Read more

  • According to GBI Research, the growth will primarily be driven by the emergence of novel therapeutics

    Drug Discovery |  News | 0 Comment | 19 Jan, 2017

    Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from USD1.7 billion in 2014 to USD2.8 ...Read more

Podcast

 

Survey Box

Can data align the pharma industry with healthcare better?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls